(Press-News.org) A team of researchers from Women & Infants Hospital of Rhode Island commanded a national stage to present the results of a study evaluating the use of sentinel lymph node dissection in women with vulvar malignancies, and then follow the patients for complications and recurrence.
The team – Drs. Richard G. Moore, Dario Roque, Carolyn McCourt, Ashley Stuckey, Paul A. DiSIlvestro, James Sung, Margaret Steinhoff, Cornelius Granai III, and Katina Robison – presented their work at the annual meeting of the Society of Gynecologic Oncologists (SGO) in Tampa. The oral presentation was part of the main plenary session at the meeting.
The study is entitled "Isolated sentinel lymph node biopsy with conservative management in women diagnosed with vulvar cancer." Using radioactive dye and blue dye, gynecologic oncology surgeons are able to identify and remove just the sentinel nodes, which is the first place cancer will go.
"The object of this study was to examine the sentinel lymph node alone in women with squamous cell carcinoma of the vulva and evaluate their recurrence in the groin and any complication rates," Dr. Moore explains. "We discovered that removing just the sentinel node had decreased complication while maintaining a low rate of further occurrence of malignancy.
"This should be considered an option for women with squamous cell carcinoma of the vulva."
The study, the largest prospective trial on sentinel lymph node dissection among women with vulvar cancer in the United States, included 73 women with 69 undergoing sentinel node dissection. Fifty seven of those women were managed conservatively. Three experienced groin recurrences, for a recurrence rate of 5.2 percent.
Women whose sentinel node tested negative for metastasis were followed clinically without further treatment. Women with metastasis to the sentinel lymph node underwent full groin node dissection and were then followed by standard treatment protocols.
INFORMATION:
For an appointment at the Program in Women's Oncology, call (401) 453-7520.
About Women & Infants Hospital
Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation's leading specialty hospitals for women and newborns. The primary teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women's medicine, Women & Infants is the eighth largest stand-alone obstetrical service in the country with nearly 8,400 deliveries per year. In 2009, Women & Infants opened the country's largest, single-family room neonatal intensive care unit.
New England's premier hospital for women and newborns, Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, women's mental health, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation's only mother-baby perinatal psychiatric partial hospital, as well as the nation's only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Center of Excellence from the American College of Radiography; a Center for In Vitro Maturation Excellence by SAGE In Vitro Fertilization; a Center of Biomedical Research Excellence by the National Institutes of Health; and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute's Gynecologic Oncology Group and the National Institutes of Health's Pelvic Floor Disorders Network.
Research: Less invasive technique possible in vulvar cancer treatment
2014-03-26
ELSE PRESS RELEASES FROM THIS DATE:
Lack of coronin 1 protein causes learning deficits and aggressive behavior
2014-03-26
This news release is available in German.
Organisms must be able to sense signals from the outside and translate these into biochemical cues in order to adequately respond to their environment. This capability is also required to process information that reaches the brain. Within the brain, stimulation of neurons activates genes that are required, for example for learning and memory. In collaboration with an international and interdisciplinary team the research group led by Prof. Jean Pieters from the Biozentrum, University of Basel, has now uncovered the role of ...
Using PET scanning to evaluate therapies of Menkes disease
2014-03-26
Scientists at the RIKEN Center for Life Science Technologies have used PET imaging to visualize the distribution in the body of copper, which is deregulated in Menkes disease, a genetic disorder, using a mouse model. This study lays the groundwork for PET imaging studies on human Menkes disease patients to identify new therapy options.
Menkes disease, though rare, is a fearsome genetic disorder. Most affected babies die within the first few years of life. The disease is caused by an inborn fault in the body's ability to absorb copper. The standard treatment today for ...
Diabetes: Good self-management helps to reduce mortality
2014-03-26
Scientists of the Institute of Health Economics and Health Care Management (IGM) and of the Institute of Epidemiology II (EPI II) at Helmholtz Zentrum München (HMGU), together with colleagues of the German Diabetes Center (DDZ) in Düsseldorf, investigated the association between self-management behavior and mortality in patients with type 2 diabetes. HMGU and the DDZ are partners in the German Center for Diabetes Research (DZD).
High self-management index – low mortality
340 study participants with type 2 diabetes were interviewed with regard to their patient behavior ...
Real-life CSI: What can investigators really tell from gunshot residue?
2014-03-26
The popular TV series "CSI" is fiction, but every day, real-life investigators and forensic scientists collect and analyze evidence to determine what happened at crime scenes. In a study published in the ACS journal Analytical Chemistry, scientists say they have developed a more rapid and accurate method that could allow crime scene investigators to tell what kind of ammunition was shot from a gun based on the residue it left behind.
Igor K. Lednev and Justin Bueno point out that when someone fires a gun, burnt particles from the bullet spray out of the weapon onto a ...
Electroacupuncture at Conception and Governor vessels and hUCB-MSCs for cerebral ischemia
2014-03-26
Mesenchymal stem cell transplantation is a novel means of treating cerebral ischemia/reperfusion, and can promote angiogenesis and neurological functional recovery. Acupuncture at Conception and Governor vessels also has positive effects as a treatment for cerebral ischemia/reperfusion. Therefore, Prof. Haibo Yu and co-workers from Affiliated Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine in China hypothesized that electro-acupuncture at Conception and Governor vessels plus mesenchymal stem cell transplantation may have better therapeutic ...
Beer marinade could reduce levels of potentially harmful substances in grilled meats
2014-03-26
The smells of summer — the sweet fragrance of newly opened flowers, the scent of freshly cut grass and the aroma of meats cooking on the backyard grill — will soon be upon us. Now, researchers are reporting that the very same beer that many people enjoy at backyard barbeques could, when used as a marinade, help reduce the formation of potentially harmful substances in grilled meats. The study appears in ACS' Journal of Agricultural and Food Chemistry.
I.M.P.L.V.O. Ferreira and colleagues explain that past studies have shown an association between consumption of grilled ...
Research produces strong evidence for a new class of antidepressant drugs
2014-03-26
Scientists have shown for the first time that a chemical in the brain called galanin is involved in the risk of developing depression.
And the research, undertaken by a European research team, points to a strong reason to develop drugs that modify galanin functioning as a new class of antidepressant drug.
Galanin is a neuropeptide (a small protein) that was discovered and investigated over 30 years ago by various groups including the Swedish scientist Tomas Hokfelt. He is one of the senior authors of the paper published in the journal PNAS.
Professor Hokfelt and ...
First images available from NASA-JAXA global rain and snowfall satellite
2014-03-26
NASA and the Japan Aerospace Exploration Agency (JAXA) have released the first images captured by their newest Earth-observing satellite, the Global Precipitation Measurement (GPM) Core Observatory, which launched into space Feb. 27.
The images show precipitation falling inside a March 10 cyclone over the northwest Pacific Ocean, approximately 1,000 miles east of Japan. The data were collected by the GPM Core Observatory's two instruments: JAXA's Dual-frequency Precipitation Radar (DPR), which imaged a three-dimensional cross-section of the storm; and, NASA's GPM Microwave ...
The advantages of entering the workforce in a recession
2014-03-26
Despite the well-documented disadvantages of graduating from college during a recession, could graduates actually be happier with their jobs in the long run?
A new article from Administrative Science Quarterly examines whether earning a college or graduate degree in a recession or an economic boom has lasting effects on job satisfaction. Across three studies, well-educated graduates who entered the workforce during economic downturns were happier with their work than those who first searched for jobs during more prosperous times. In fact, they were happier with their ...
Immunotherapy data heralds new era of lung cancer treatment
2014-03-26
Geneva, Switzerland, 26 March 2014 -- A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumour cells from evading the immune system, experts have said at the 4th European Lung Cancer Congress.
For decades, scientists and doctors thought immunotherapy –treatments that harness the immune system to fight a disease-- was of marginal benefit in lung cancer, says Jean-Charles Soria, Institute Gustave Roussy in Paris, France.
However a new class of drugs known as "immunocheckpoint regulators" have shown huge potential, Soria says. New data ...